| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President &Immunovant CEO | President &COO | Chief Operating Officer
1 company
Venker Eric serves as a President &Immunovant CEO at ROIV. Across recent SEC filings that breaks down to 0 buys and 85 sells. Those positions are worth an estimated $58.4M at current prices.
Historically, Venker Eric's trades have earned a below-average insider score of 42/100 across 81 rated trades. Over a 12-month horizon, 16.1% of those trades were profitable, with an average 12-month return of -44.5%.
The biggest single holding is ROIV (~$58.4M) as President &Immunovant CEO. The recent filings there lean toward selling, a net 12,977,626 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 21, 2025 | ROIV Roivant Sciences Ltd. | President &COO | Sale+OE | 100,000 | $11.28 | $1,128,000.00 | -12.0% | -10.9% | +103.9% | |
| Dec 30, 2024 | ROIV Roivant Sciences Ltd. | President &COO | Sale+OE | 354,604 | $11.68 | $4,141,662.16 | -20.1% | -11.7% | +89.2% | |
| Dec 20, 2024 | ROIV Roivant Sciences Ltd. | President &COO | Sale+OE | 100,000 | $11.49 | $1,149,000.00 | -14.4% | -5.2% | +93.7% | |
| Nov 20, 2024 | ROIV Roivant Sciences Ltd. | President &COO | Sale+OE | 100,000 | $11.32 | $1,132,000.00 | -14.2% | -7.0% | +76.4% | |
| Oct 21, 2024 | ROIV Roivant Sciences Ltd. | President &COO | Sale+OE | 100,000 | $11.65 | $1,165,000.00 | -13.9% | -3.0% | +53.8% | |
| Feb 9, 2024 | ROIV Roivant Sciences Ltd. | President &COO | Sale+OE | 96,950 | $10.92 | $1,058,694.00 | -15.4% | +4.1% | +0.7% | |
| Oct 5, 2023 | ROIV Roivant Sciences Ltd. | Chief Operating Officer | Sale+OE | 1,200,000 | $10.43 | $12,520,989.82 | -40.2% | +4.1% | +9.1% | |
| Sep 27, 2023 | ROIV Roivant Sciences Ltd. | President &COO | Sale+OE | 500,000 | $13.02 | $6,510,000.00 | -45.6% | -13.0% | -12.3% | |
| Sep 8, 2023 | ROIV Roivant Sciences Ltd. | Chief Operating Officer | Sale+OE | 106,430 | $12.19 | $1,297,381.70 | -14.8% | -22.6% | -2.4% | |
| Sep 6, 2023 | ROIV Roivant Sciences Ltd. | Chief Operating Officer | Sale+OE | 93,964 | $11.91 | $1,119,340.80 | -4.9% | -16.7% | +3.4% |